Precigen (PGEN) Common Equity: 2012-2025
Historic Common Equity for Precigen (PGEN) over the last 13 years, with Sep 2025 value amounting to $41.9 million.
- Precigen's Common Equity fell 24.39% to $41.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.9 million, marking a year-over-year decrease of 24.39%. This contributed to the annual value of $38.5 million for FY2024, which is 67.50% down from last year.
- As of Q3 2025, Precigen's Common Equity stood at $41.9 million, which was up 213.84% from -$36.8 million recorded in Q2 2025.
- Precigen's 5-year Common Equity high stood at $184.1 million for Q1 2023, and its period low was -$36.8 million during Q2 2025.
- Over the past 3 years, Precigen's median Common Equity value was $55.4 million (recorded in 2024), while the average stood at $76.5 million.
- In the last 5 years, Precigen's Common Equity skyrocketed by 221.34% in 2021 and then crashed by 185.20% in 2025.
- Quarterly analysis of 5 years shows Precigen's Common Equity stood at $107.3 million in 2021, then grew by 17.62% to $126.3 million in 2022, then declined by 6.15% to $118.5 million in 2023, then plummeted by 67.50% to $38.5 million in 2024, then fell by 24.39% to $41.9 million in 2025.
- Its last three reported values are $41.9 million in Q3 2025, -$36.8 million for Q2 2025, and -$14.1 million during Q1 2025.